ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transcatheter Heart Valve Therapies Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-30T17144
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Transcatheter Heart Valve Therapies Market Research Report 2024
BUY CHAPTERS

Global Transcatheter Heart Valve Therapies Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-30T17144
Report
October 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Edwards Lifesciences
Mitralign
Cardiac Dimensions
NeoChord
Hanyu Medical
Valgen Medtech

Transcatheter Heart Valve Therapies Market

The global Transcatheter Heart Valve Therapies market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Transcatheter heart valve therapies refer to minimally invasive procedures used to treat heart valve diseases, such as aortic stenosis or mitral regurgitation, without the need for open-heart surgery. During these procedures, a collapsible artificial valve is inserted into the heart via a catheter, typically through a blood vessel in the groin or chest. Once in position, the valve is expanded, replacing the damaged or diseased native valve and restoring proper blood flow. These innovative therapies offer significant advantages over traditional surgical approaches, including reduced recovery times, fewer complications, and improved outcomes for patients deemed high-risk or inoperable for conventional surgery.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Transcatheter Heart Valve Therapies leading manufacturers including Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, Hanyu Medical, Valgen Medtech, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Transcatheter Heart Valve Therapies market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Transcatheter Heart Valve Therapies Market Report

Report Metric Details
Report Name Transcatheter Heart Valve Therapies Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, Hanyu Medical, Valgen Medtech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Transcatheter Heart Valve Therapies study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Transcatheter Heart Valve Therapies Market report?

Ans: The main players in the Transcatheter Heart Valve Therapies Market are Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, Hanyu Medical, Valgen Medtech

What are the Application segmentation covered in the Transcatheter Heart Valve Therapies Market report?

Ans: The Applications covered in the Transcatheter Heart Valve Therapies Market report are Hospital, Clinic

What are the Type segmentation covered in the Transcatheter Heart Valve Therapies Market report?

Ans: The Types covered in the Transcatheter Heart Valve Therapies Market report are Restorative Interventional Devices, Replacement Interventional Devices

Recommended Reports

Heart Valve Devices

Cardiac Catheters

Interventional Cardiology

1 Study Coverage
1.1 Introduction to Transcatheter Heart Valve Therapies: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Transcatheter Heart Valve Therapies Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Restorative Interventional Devices
1.2.3 Replacement Interventional Devices
1.3 Market Segmentation by Application
1.3.1 Global Transcatheter Heart Valve Therapies Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transcatheter Heart Valve Therapies Revenue Estimates and Forecasts 2020-2031
2.2 Global Transcatheter Heart Valve Therapies Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Transcatheter Heart Valve Therapies Sales Estimates and Forecasts 2020-2031
2.4 Global Transcatheter Heart Valve Therapies Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Transcatheter Heart Valve Therapies Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Transcatheter Heart Valve Therapies Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Restorative Interventional Devices Market Size by Manufacturers
3.5.2 Replacement Interventional Devices Market Size by Manufacturers
3.6 Global Transcatheter Heart Valve Therapies Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Transcatheter Heart Valve Therapies Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Transcatheter Heart Valve Therapies Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Transcatheter Heart Valve Therapies Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Transcatheter Heart Valve Therapies Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Transcatheter Heart Valve Therapies Sales and Revenue by Type (2020-2031)
6.4 North America Transcatheter Heart Valve Therapies Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Transcatheter Heart Valve Therapies Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Transcatheter Heart Valve Therapies Sales and Revenue by Type (2020-2031)
7.4 Europe Transcatheter Heart Valve Therapies Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Transcatheter Heart Valve Therapies Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Transcatheter Heart Valve Therapies Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Transcatheter Heart Valve Therapies Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Transcatheter Heart Valve Therapies Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Transcatheter Heart Valve Therapies Sales and Revenue by Type (2020-2031)
9.4 Central and South America Transcatheter Heart Valve Therapies Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Transcatheter Heart Valve Therapies Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Transcatheter Heart Valve Therapies Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Transcatheter Heart Valve Therapies Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Transcatheter Heart Valve Therapies Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.1.4 Abbott Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Transcatheter Heart Valve Therapies Sales by Product in 2024
11.1.6 Abbott Transcatheter Heart Valve Therapies Sales by Application in 2024
11.1.7 Abbott Transcatheter Heart Valve Therapies Sales by Geographic Area in 2024
11.1.8 Abbott Transcatheter Heart Valve Therapies SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Edwards Lifesciences
11.2.1 Edwards Lifesciences Corporation Information
11.2.2 Edwards Lifesciences Business Overview
11.2.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.2.4 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales by Product in 2024
11.2.6 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales by Application in 2024
11.2.7 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales by Geographic Area in 2024
11.2.8 Edwards Lifesciences Transcatheter Heart Valve Therapies SWOT Analysis
11.2.9 Edwards Lifesciences Recent Developments
11.3 Mitralign
11.3.1 Mitralign Corporation Information
11.3.2 Mitralign Business Overview
11.3.3 Mitralign Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.3.4 Mitralign Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Mitralign Transcatheter Heart Valve Therapies Sales by Product in 2024
11.3.6 Mitralign Transcatheter Heart Valve Therapies Sales by Application in 2024
11.3.7 Mitralign Transcatheter Heart Valve Therapies Sales by Geographic Area in 2024
11.3.8 Mitralign Transcatheter Heart Valve Therapies SWOT Analysis
11.3.9 Mitralign Recent Developments
11.4 Cardiac Dimensions
11.4.1 Cardiac Dimensions Corporation Information
11.4.2 Cardiac Dimensions Business Overview
11.4.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.4.4 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales by Product in 2024
11.4.6 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales by Application in 2024
11.4.7 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales by Geographic Area in 2024
11.4.8 Cardiac Dimensions Transcatheter Heart Valve Therapies SWOT Analysis
11.4.9 Cardiac Dimensions Recent Developments
11.5 NeoChord
11.5.1 NeoChord Corporation Information
11.5.2 NeoChord Business Overview
11.5.3 NeoChord Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.5.4 NeoChord Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 NeoChord Transcatheter Heart Valve Therapies Sales by Product in 2024
11.5.6 NeoChord Transcatheter Heart Valve Therapies Sales by Application in 2024
11.5.7 NeoChord Transcatheter Heart Valve Therapies Sales by Geographic Area in 2024
11.5.8 NeoChord Transcatheter Heart Valve Therapies SWOT Analysis
11.5.9 NeoChord Recent Developments
11.6 Hanyu Medical
11.6.1 Hanyu Medical Corporation Information
11.6.2 Hanyu Medical Business Overview
11.6.3 Hanyu Medical Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.6.4 Hanyu Medical Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hanyu Medical Recent Developments
11.7 Valgen Medtech
11.7.1 Valgen Medtech Corporation Information
11.7.2 Valgen Medtech Business Overview
11.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Product Models, Descriptions and Specifications
11.7.4 Valgen Medtech Transcatheter Heart Valve Therapies Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Valgen Medtech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Transcatheter Heart Valve Therapies Industry Chain
12.2 Transcatheter Heart Valve Therapies Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Transcatheter Heart Valve Therapies Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Transcatheter Heart Valve Therapies Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Transcatheter Heart Valve Therapies Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Transcatheter Heart Valve Therapies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Abbott
Edwards Lifesciences
Mitralign
Cardiac Dimensions
NeoChord
Hanyu Medical
Valgen Medtech
List of Tables
 Table 1. Global Transcatheter Heart Valve Therapies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Transcatheter Heart Valve Therapies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Transcatheter Heart Valve Therapies Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Transcatheter Heart Valve Therapies Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Transcatheter Heart Valve Therapies Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Transcatheter Heart Valve Therapies Sales by Region (2020-2025) & (Units)
 Table 8. Global Transcatheter Heart Valve Therapies Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Transcatheter Heart Valve Therapies Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Transcatheter Heart Valve Therapies Sales Share by Manufacturers (2020-2025)
 Table 12. Global Transcatheter Heart Valve Therapies Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Transcatheter Heart Valve Therapies Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Transcatheter Heart Valve Therapies by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Heart Valve Therapies as of 2024)
 Table 16. Global Transcatheter Heart Valve Therapies Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Transcatheter Heart Valve Therapies Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Transcatheter Heart Valve Therapies Manufacturing Base and Headquarters
 Table 19. Global Transcatheter Heart Valve Therapies Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Transcatheter Heart Valve Therapies Sales by Type (2020-2025) & (Units)
 Table 23. Global Transcatheter Heart Valve Therapies Sales by Type (2026-2031) & (Units)
 Table 24. Global Transcatheter Heart Valve Therapies Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Transcatheter Heart Valve Therapies Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Transcatheter Heart Valve Therapies ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Transcatheter Heart Valve Therapies Sales by Application (2020-2025) & (Units)
 Table 29. Global Transcatheter Heart Valve Therapies Sales by Application (2026-2031) & (Units)
 Table 30. Transcatheter Heart Valve Therapies High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Transcatheter Heart Valve Therapies Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Transcatheter Heart Valve Therapies Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Transcatheter Heart Valve Therapies ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Transcatheter Heart Valve Therapies Growth Accelerators and Market Barriers
 Table 37. North America Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Transcatheter Heart Valve Therapies Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Transcatheter Heart Valve Therapies Growth Accelerators and Market Barriers
 Table 40. Europe Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Transcatheter Heart Valve Therapies Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Transcatheter Heart Valve Therapies Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Transcatheter Heart Valve Therapies Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Transcatheter Heart Valve Therapies Investment Opportunities and Key Challenges
 Table 47. Central and South America Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Transcatheter Heart Valve Therapies Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Transcatheter Heart Valve Therapies Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Abbott Corporation Information
 Table 51. Abbott Description and Major Businesses
 Table 52. Abbott Product Models, Descriptions and Specifications
 Table 53. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Abbott Sales Value Proportion by Product in 2024
 Table 55. Abbott Sales Value Proportion by Application in 2024
 Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 57. Abbott Transcatheter Heart Valve Therapies SWOT Analysis
 Table 58. Abbott Recent Developments
 Table 59. Edwards Lifesciences Corporation Information
 Table 60. Edwards Lifesciences Description and Major Businesses
 Table 61. Edwards Lifesciences Product Models, Descriptions and Specifications
 Table 62. Edwards Lifesciences Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Edwards Lifesciences Sales Value Proportion by Product in 2024
 Table 64. Edwards Lifesciences Sales Value Proportion by Application in 2024
 Table 65. Edwards Lifesciences Sales Value Proportion by Geographic Area in 2024
 Table 66. Edwards Lifesciences Transcatheter Heart Valve Therapies SWOT Analysis
 Table 67. Edwards Lifesciences Recent Developments
 Table 68. Mitralign Corporation Information
 Table 69. Mitralign Description and Major Businesses
 Table 70. Mitralign Product Models, Descriptions and Specifications
 Table 71. Mitralign Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Mitralign Sales Value Proportion by Product in 2024
 Table 73. Mitralign Sales Value Proportion by Application in 2024
 Table 74. Mitralign Sales Value Proportion by Geographic Area in 2024
 Table 75. Mitralign Transcatheter Heart Valve Therapies SWOT Analysis
 Table 76. Mitralign Recent Developments
 Table 77. Cardiac Dimensions Corporation Information
 Table 78. Cardiac Dimensions Description and Major Businesses
 Table 79. Cardiac Dimensions Product Models, Descriptions and Specifications
 Table 80. Cardiac Dimensions Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Cardiac Dimensions Sales Value Proportion by Product in 2024
 Table 82. Cardiac Dimensions Sales Value Proportion by Application in 2024
 Table 83. Cardiac Dimensions Sales Value Proportion by Geographic Area in 2024
 Table 84. Cardiac Dimensions Transcatheter Heart Valve Therapies SWOT Analysis
 Table 85. Cardiac Dimensions Recent Developments
 Table 86. NeoChord Corporation Information
 Table 87. NeoChord Description and Major Businesses
 Table 88. NeoChord Product Models, Descriptions and Specifications
 Table 89. NeoChord Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. NeoChord Sales Value Proportion by Product in 2024
 Table 91. NeoChord Sales Value Proportion by Application in 2024
 Table 92. NeoChord Sales Value Proportion by Geographic Area in 2024
 Table 93. NeoChord Transcatheter Heart Valve Therapies SWOT Analysis
 Table 94. NeoChord Recent Developments
 Table 95. Hanyu Medical Corporation Information
 Table 96. Hanyu Medical Description and Major Businesses
 Table 97. Hanyu Medical Product Models, Descriptions and Specifications
 Table 98. Hanyu Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. Hanyu Medical Recent Developments
 Table 100. Valgen Medtech Corporation Information
 Table 101. Valgen Medtech Description and Major Businesses
 Table 102. Valgen Medtech Product Models, Descriptions and Specifications
 Table 103. Valgen Medtech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. Valgen Medtech Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Transcatheter Heart Valve Therapies Product Picture
 Figure 2. Global Transcatheter Heart Valve Therapies Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Restorative Interventional Devices Product Picture
 Figure 4. Replacement Interventional Devices Product Picture
 Figure 5. Global Transcatheter Heart Valve Therapies Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Transcatheter Heart Valve Therapies Report Years Considered
 Figure 9. Global Transcatheter Heart Valve Therapies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Transcatheter Heart Valve Therapies Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Transcatheter Heart Valve Therapies Revenue Market Share by Region (2020-2031)
 Figure 13. Global Transcatheter Heart Valve Therapies Sales (2020-2031) & (Units)
 Figure 14. Global Transcatheter Heart Valve Therapies Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Transcatheter Heart Valve Therapies Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Transcatheter Heart Valve Therapies Sales Volume Market Share in 2024
 Figure 17. Global Transcatheter Heart Valve Therapies Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Restorative Interventional Devices Revenue Market Share by Manufacturer in 2024
 Figure 20. Replacement Interventional Devices Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Transcatheter Heart Valve Therapies Sales Market Share by Type (2020-2031)
 Figure 22. Global Transcatheter Heart Valve Therapies Revenue Market Share by Type (2020-2031)
 Figure 23. Global Transcatheter Heart Valve Therapies Sales Market Share by Application (2020-2031)
 Figure 24. Global Transcatheter Heart Valve Therapies Revenue Market Share by Application (2020-2031)
 Figure 25. North America Transcatheter Heart Valve Therapies Sales YoY (2020-2031) & (Units)
 Figure 26. North America Transcatheter Heart Valve Therapies Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) in 2024
 Figure 28. North America Transcatheter Heart Valve Therapies Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Transcatheter Heart Valve Therapies Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Transcatheter Heart Valve Therapies Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Transcatheter Heart Valve Therapies Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Transcatheter Heart Valve Therapies Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Transcatheter Heart Valve Therapies Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 43. France Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Transcatheter Heart Valve Therapies Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Transcatheter Heart Valve Therapies Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Transcatheter Heart Valve Therapies Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Transcatheter Heart Valve Therapies Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 58. India Transcatheter Heart Valve Therapies Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Transcatheter Heart Valve Therapies Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Transcatheter Heart Valve Therapies Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Transcatheter Heart Valve Therapies Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Transcatheter Heart Valve Therapies Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Transcatheter Heart Valve Therapies Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Transcatheter Heart Valve Therapies Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Transcatheter Heart Valve Therapies Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Transcatheter Heart Valve Therapies Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Transcatheter Heart Valve Therapies Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Transcatheter Heart Valve Therapies Revenue (2020-2025) & (US$ Million)
 Figure 79. Transcatheter Heart Valve Therapies Industry Chain Mapping
 Figure 80. Regional Transcatheter Heart Valve Therapies Manufacturing Base Distribution (%)
 Figure 81. Global Transcatheter Heart Valve Therapies Production Market Share by Region (2020-2031)
 Figure 82. Transcatheter Heart Valve Therapies Production Process
 Figure 83. Regional Transcatheter Heart Valve Therapies Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Transcatheter Mitral Valve Treatment Devices Market Research Report 2024
Global Transcatheter Aortic Valve System Market Research Report 2025
Global Transcatheter Aortic Valve Replacement Service Market Research Report 2024
Global Transcatheter Aortic Valve Replacement TAVR Market Research Report 2025
Interventional Heart Valve Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcathetar Devices Market Research Report 2024
Global Transcatheter Aortic Valve Implantation TAVI Market Insights Forecast to 2030
Global Tanscatheter Mitral Valve Repair and Replacement Market Insights Forecast to 2030
Global Transcatheter Mitral Valve Intervention Market Research Report 2024
Global Transcatheter Mitral Valve Replacement TMVR Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Transcatheter Heart Valve Replacement and Repair Market Insights Forecast to 2030
Transcatheter Pulmonary Valve Replacement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Aortic Valve Market Research Report 2024
Global Transcatheter Aortic Heart Valve Device Market Research Report 2024
Global Transcatheter Tricuspid Valve Replacement TTVR Technology Market Research Report 2024
Global Transcatheter Structural Heart Device Market Research Report 2024
Global Heart Valve Interventional Equipment Market Research Report 2024
Global Transcatheter Devices Market Insights Forecast to 2030
Interventional Devices for Structural Heart Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transcatheter Tricuspid Valve Replacement TTVR and Transcatheter Tricuspid Valve Repair TTVr Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions